| scholarly article | Q13442814 |
| P2093 | author name string | Feng Zhang | |
| Wei Liu | |||
| Qi Liu | |||
| Feifei Liu | |||
| Hao Xiang | |||
| Yu Dong | |||
| Peng Song | |||
| Xiangyu Li | |||
| Ziying Qiu | |||
| P2860 | cites work | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 |
| Sifting the evidence-what's wrong with significance tests? | Q24524896 | ||
| Prognostic significance of differentially expressed miRNAs in esophageal cancer | Q24612881 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| The Three Paralogous MicroRNA Clusters in Development and Disease, miR-17-92, miR-106a-363, and miR-106b-25 | Q26748969 | ||
| Oncogenic MicroRNAs: Key Players in Malignant Transformation | Q26773316 | ||
| MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis | Q26785371 | ||
| Global cancer statistics, 2012 | Q27860501 | ||
| MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion | Q28290246 | ||
| Overexpression of miRNA-221 promotes cell proliferation by targeting the apoptotic protease activating factor-1 and indicates a poor prognosis in ovarian cancer | Q32179591 | ||
| Downregulation of miR-92a is associated with aggressive breast cancer features and increased tumour macrophage infiltration | Q34259934 | ||
| Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma | Q34667439 | ||
| Deregulated expression of miR-106a predicts survival in human colon cancer patients | Q34784235 | ||
| Curated microRNAs in urine and blood fail to validate as predictive biomarkers for high-risk prostate cancer | Q35140145 | ||
| Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer | Q35782978 | ||
| Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease | Q35802368 | ||
| microRNA-17~92 is a powerful cancer driver and a therapeutic target | Q87088247 | ||
| Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer | Q35863159 | ||
| Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma | Q35926157 | ||
| Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma | Q36070798 | ||
| Regulatory Role of miR-203 in Occurrence and Progression of Kazakh Esophageal squamous cell carcinoma | Q36748596 | ||
| MiR-106a is an independent prognostic marker in patients with glioblastoma | Q36865988 | ||
| Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma | Q36976141 | ||
| Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison | Q37472263 | ||
| miR-17∼92 family clusters control iNKT cell ontogenesis via modulation of TGF-β signaling | Q37534350 | ||
| Gastric metastasis of bilateral breast cancer | Q37677532 | ||
| MicroRNAs as prognostic molecular signatures in human head and neck squamous cell carcinoma: a systematic review and meta-analysis. | Q38354056 | ||
| Upregulation of miRNA-17 and miRNA-19 is associated with unfavorable prognosis in patients with T-cell lymphoblastic lymphoma | Q38385126 | ||
| The Profile of Serum microRNAs Predicts Prognosis for Resected Gastric Cancer Patients Receiving Platinum-Based Chemotherapy. | Q38710597 | ||
| miR-18a promotes cell proliferation of esophageal squamous cell carcinoma cells by increasing cylin D1 via regulating PTEN-PI3K-AKT-mTOR signaling axis | Q38764921 | ||
| A miRNAs panel promotes the proliferation and invasion of colorectal cancer cells by targeting GABBR1. | Q38768235 | ||
| MicroRNA expression patterns and signalling pathways in the development and progression of childhood solid tumours. | Q38768383 | ||
| Strategies to design clinical studies to identify predictive biomarkers in cancer research. | Q38770451 | ||
| miR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis | Q38780780 | ||
| Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the Clinical Outcome in Colorectal Cancer | Q38876048 | ||
| Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value | Q38934494 | ||
| MiR-17-92 cluster promotes hepatocarcinogenesis | Q39061756 | ||
| Three or More Courses of Stereotactic Radiosurgery for Patients with Multiply Recurrent Brain Metastases | Q39192811 | ||
| miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma | Q39526640 | ||
| KLK6-regulated miRNA networks activate oncogenic pathways in breast cancer subtypes | Q39839292 | ||
| Expression of microRNA-106b and its clinical significance in cutaneous melanoma | Q40216692 | ||
| A basic introduction to fixed-effect and random-effects models for meta-analysis | Q40850000 | ||
| Increased expression of microRNA-17 predicts poor prognosis in human glioma | Q41808943 | ||
| Serum levels of miR-19b and miR-146a as prognostic biomarkers for non-small cell lung cancer | Q44030040 | ||
| Prognostic significance of serum miR-17-5p in lung cancer | Q44140172 | ||
| Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer | Q44499697 | ||
| MiR-17-92 cluster is a novel regulatory gene of cardiac ischemic/reperfusion injury. | Q46752151 | ||
| The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma | Q48277168 | ||
| MicroRNA-17, microRNA-18a, and microRNA-19a are prognostic indicators in esophageal squamous cell carcinoma. | Q50465888 | ||
| miR-17-92/p38α Dysregulation Enhances Wnt Signaling and Selects Lgr6+ Cancer Stem-like Cells during Lung Adenocarcinoma Progression. | Q53096425 | ||
| Prognostic value of miR-106b expression in breast cancer patients. | Q53628965 | ||
| Prognostic values of the miR-17-92 cluster and its paralogs in colon cancer. | Q54005010 | ||
| Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer. | Q54301912 | ||
| Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. | Q54590406 | ||
| Prognostic impact of disseminated tumor cells and microRNA-17-92 cluster deregulation in gastrointestinal cancer | Q84534578 | ||
| MiR-15a, miR-16-1 and miR-17-92 cluster expression are linked to poor prognosis in multiple myeloma | Q84949141 | ||
| Global cancer cases on the rise | Q85326774 | ||
| P433 | issue | 40 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 69125-69138 | |
| P577 | publication date | 2017-07-08 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Prognostic role of miR-17-92 family in human cancers: evaluation of multiple prognostic outcomes | |
| P478 | volume | 8 |
| Q60947611 | Change of Circulating and Tissue-Based miR-20a in Human Cancers and Associated Prognostic Implication: A Systematic Review and Meta-Analysis |
| Q92627504 | Investigation of MiR-92a as a Prognostic Indicator in Cancer Patients: a Meta-Analysis |
| Q92666695 | MIR17HG-miR-18a/19a axis, regulated by interferon regulatory factor-1, promotes gastric cancer metastasis via Wnt/β-catenin signalling |
| Q64262359 | MiR-19a as a prognostic indicator for cancer patients: a meta-analysis |
| Q90381861 | Micro RNA Transcriptome Profile in Canine Oral Melanoma |
| Q47149007 | Novel circulating microRNAs expression profile in colon cancer: a pilot study |
| Q49378677 | Pterostilbene increases PTEN expression through the targeted downregulation of microRNA-19a in hepatocellular carcinoma |
| Q64054839 | TACCO, a Database Connecting Transcriptome Alterations, Pathway Alterations and Clinical Outcomes in Cancers |
| Q92735477 | Upregulation of miR-17-92 cluster is associated with progression and lymph node metastasis in oesophageal adenocarcinoma |
| Q90414205 | miRNAs in the Diagnosis and Prognosis of Skin Cancer |
Search more.